These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 11079502

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene.
    Mandell RB, Mandell LZ, Link CJ.
    Cancer Res; 1999 Feb 01; 59(3):661-8. PubMed ID: 9973215
    [Abstract] [Full Text] [Related]

  • 4. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 1999 May 01; 59(9):2136-41. PubMed ID: 10232600
    [Abstract] [Full Text] [Related]

  • 5. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E, Unfer R, Vahanian N, Link C.
    Gene Ther; 2006 Jul 01; 13(13):1052-6. PubMed ID: 16525480
    [Abstract] [Full Text] [Related]

  • 6. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Göke B, Morris JC, Spitzweg C.
    Gene Ther; 2008 Feb 01; 15(3):214-23. PubMed ID: 17989705
    [Abstract] [Full Text] [Related]

  • 7. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models.
    Carlin S, Cunningham SH, Boyd M, McCluskey AG, Mairs RJ.
    Cancer Gene Ther; 2000 Dec 01; 7(12):1529-36. PubMed ID: 11228531
    [Abstract] [Full Text] [Related]

  • 8. Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene.
    Shimura H, Haraguchi K, Miyazaki A, Endo T, Onaya T.
    Endocrinology; 1997 Oct 01; 138(10):4493-6. PubMed ID: 9322970
    [Abstract] [Full Text] [Related]

  • 9. Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells.
    Haberkorn U, Beuter P, Kübler W, Eskerski H, Eisenhut M, Kinscherf R, Zitzmann S, Strauss LG, Dimitrakopoulou-Strauss A, Altmann A.
    J Nucl Med; 2004 May 01; 45(5):827-33. PubMed ID: 15136633
    [Abstract] [Full Text] [Related]

  • 10. Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells.
    Schipper ML, Weber A, Béhé M, Göke R, Joba W, Schmidt H, Bert T, Simon B, Arnold R, Heufelder AE, Behr TM.
    Cancer Res; 2003 Mar 15; 63(6):1333-8. PubMed ID: 12649195
    [Abstract] [Full Text] [Related]

  • 11. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
    Smit JW, Schröder-van der Elst JP, Karperien M, Que I, Romijn JA, van der Heide D.
    Exp Clin Endocrinol Diabetes; 2001 Mar 15; 109(1):52-5. PubMed ID: 11573141
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter.
    Park SY, Kwak W, Thapa N, Jung MY, Nam JO, So IS, Kim SY, Yoo J, Lee J, Kim IS.
    J Nucl Med; 2008 Sep 15; 49(9):1480-8. PubMed ID: 18703598
    [Abstract] [Full Text] [Related]

  • 14. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
    Dwyer RM, Bergert ER, O'connor MK, Gendler SJ, Morris JC.
    Clin Cancer Res; 2005 Feb 15; 11(4):1483-9. PubMed ID: 15746050
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.
    Chen L, Altmann A, Mier W, Eskerski H, Leotta K, Guo L, Zhu R, Haberkorn U.
    J Nucl Med; 2006 May 15; 47(5):854-62. PubMed ID: 16644756
    [Abstract] [Full Text] [Related]

  • 17. The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells.
    Heltemes LM, Hagan CR, Mitrofanova EE, Panchal RG, Guo J, Link CJ.
    Cancer Gene Ther; 2003 Jan 15; 10(1):14-22. PubMed ID: 12489024
    [Abstract] [Full Text] [Related]

  • 18. Gene therapy with sodium/iodide symporter in hepatocarcinoma.
    Haberkorn U.
    Exp Clin Endocrinol Diabetes; 2001 Jan 15; 109(1):60-2. PubMed ID: 11573143
    [Abstract] [Full Text] [Related]

  • 19. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
    Klutz K, Russ V, Willhauck MJ, Wunderlich N, Zach C, Gildehaus FJ, Göke B, Wagner E, Ogris M, Spitzweg C.
    Clin Cancer Res; 2009 Oct 01; 15(19):6079-86. PubMed ID: 19789324
    [Abstract] [Full Text] [Related]

  • 20. Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter.
    Dingli D, Bergert ER, Bajzer Z, O'connor MK, Russell SJ, Morris JC.
    Biochem Biophys Res Commun; 2004 Dec 03; 325(1):157-66. PubMed ID: 15522214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.